HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA budget

This article was originally published in The Rose Sheet

Executive Summary

Senate cloture vote to end debate on Agriculture Appropriations bill (S 1233), which includes the FDA FY 2000 budget, is expected the week of July 12. A cloture vote proposed by Senate Majority Leader Trent Lott (R-Miss.) failed June 28 (1"The Rose Sheet" June 28, In Brief). Cloture was primarily rejected because of attempts by the Democrats to attach a Patients Bill of Rights amendment to the bill. Appropriations are expected to move forward; Sen. Lott and Senate Minority Leader Tom Daschle (D-S.D.) came to an agreement establishing the Patients Bill of Rights as a stand-alone bill

You may also be interested in...



FDA Budget

Cloture motion filed on Agriculture Appropriations bill (S 1233), which includes the FDA FY 2000 budget, by Senate Majority Leader Trent Lott (R-Miss.) June 24. Movement on the ag bill has been stalled due to an attempt by Democrats to attach a Patients Bill of Rights amendment. Votes to end debate on Agriculture as well as Transportation, Commerce-State-Justice and Foreign Operations bills are scheduled for 5:30 p.m. on June 28

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

UsernamePublicRestriction

Register

LL1132247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel